We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Exercise May Lead to More Rapid Prostate Tumor Growth

By Biotechdaily staff writers
Posted on 13 May 2008
Prostate tumors grew more rapidly in mice who exercised than in those who did not, leading to supposition that exercise may increase blood flow to tumors, according to new research. More...


"Our study showed that exercise led to significantly greater tumor growth than a more sedentary lifestyle did, in this mouse model,” said Lee Jones, Ph.D., a researcher in the Duke [University] Comprehensive Cancer Center (DCCC; Durham, NC, USA) and senior investigator on this study. "Our thought is that we may, in the future, be able to use this finding to design better drug delivery models to more effectively treat prostate cancer patients, and those with other types of cancer as well.”

The study's findings were presented at the American Association for Cancer Research annual meeting on April 13, 2008, in San Diego, CA, USA. The researchers implanted prostate tumors subcutaneously in the flanks of 50 mice and then put 50% of the mice in cages with exercise wheels, and half in cages with no wheels. All mice were fed the same diet. On average, the exercising mice ran more than half a mile each day. "We found that among the mice that had the opportunity to voluntarily exercise, tumors grew approximately twice as fast as they did among the mice that did not have the opportunity to exercise,” Dr. Jones stated.

Researchers and clinicians know that a challenge in delivering chemotherapy and radiation to tumors can be their poor blood flow, so these findings may provide clues towards a way in which to improve blood flow to tumors, perhaps then allowing for better distribution of medicine, according to Dr. Jones. "We're wondering, can we combine exercise with treatments such as chemotherapy, hormone therapy or radiation, to maximize the results we achieve in prostate cancer patients,” Dr. Jones said. "That question will be the subject of subsequent studies.”

The researchers are currently conducting a validation study, in mice, in which tumors are injected directly into the prostate, thereby better simulating human prostate cancer, according to Dr. Jones. "Down the line, we will test this hypothesis in humans undergoing medical treatment for prostate cancer,” he said.

The researchers want to caution men against interpreting these findings as an endorsement for not exercising for fear of getting or exacerbating cancer. "These mice were not receiving treatment and we were allowing aggressive tumors to grow unchecked for the sake of the experiment, said study investigator Dr. Stephen Freedland, one of the study's investigators and a urologist at Duke. "Patients would not find themselves in the same situation.”

Concerns should also be overridden by the well-established benefits of exercise, including its positive effects on cardiovascular health, type II diabetes, obesity, and many other chronic conditions. "This study gives us insight into which cellular pathways are affected by exercise, and starts to give us clues about how to harness the beneficial effects,” said Michael Potter, a medical student at Duke and lead investigator on the study. "Ultimately, we hope that this knowledge will help us use exercise to both deliver medicines more effectively and protect the body from the harmful side effects of treatment, as we already know it can.”

This is one of the first studies to look at the physiologic effects of exercise on the tumor itself, instead of assessing the quality-of-life or symptom-control effects of exercise in cancer patients, according to Dr. Jones "The findings were a bit surprising, but provide a very important and exciting foundation upon which to build.”


Related Links:
Duke [University] Comprehensive Cancer Center

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.